GLP-1 Agonists liraglutide (Saxenda) semaglutide (Wegovy) GIP/GLP-1 Agonist tirzepatide (Zepbound) In addition to helping you lose weight, GLP-1 and dual GIP/GLP-1 agonists can help lower your risk of some conditions that go hand in hand with obesity: type 2 diabetes, heart disease, heart failure, kidney disease, metabolic dysfunctionassociated steatotic liver disease, and obstructive sleep apnea
However, it has not been confirmed to help with the detox of any other organ or part of the body
On April 1, 2026, the FDA approved Eli Lillys Foundayo (orforglipron) the first oral GLP-1 receptor agonist for weight loss that can be taken any time of day without food or water restrictions
These capsules are useful in providing skin-lightening benefits and managing skin and other disorders because of their ability to treat dryness of skin, fight against the free radicals, manage hair fall, rejuvenate the body, support the digestive system, and balance the bodys Vata, Pitta and Kaphadoshas
23: AbbVies Humira got hit with another biosimilar on Friday as the FDA approved Alvotech and Tevas Simlandi (adalimumab-ryvk)